Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.59
+0.18 (2.43%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Evolus Employees
Evolus had 350 employees as of March 31, 2026. The number of employees increased by 16 or 4.79% since the number was last reported on December 31, 2025.
Employees
350
Change
16
Growth
4.79%
Revenue / Employee
$904,251
Profits / Employee
-$98,094
Market Cap
501.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 350 | 16 | 4.79% |
| Dec 31, 2025 | 334 | 2 | 0.60% |
| Dec 31, 2024 | 332 | 59 | 21.61% |
| Dec 31, 2023 | 273 | 58 | 26.98% |
| Dec 31, 2022 | 215 | 48 | 28.74% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,526 |
| Tilray Brands | 3,595 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 1,128 |
| Kamada | 462 |
| Glass House Brands | 426 |
| Anika Therapeutics | 235 |
| Alpha Teknova | 158 |
EOLS News
- 4 days ago - Evolus reports Q2 EPS (12c), consensus (4c) - TheFly
- 4 days ago - Evolus raises FY26 revenue view to $330M-$337M from $327M-$337M - TheFly
- 4 days ago - Evolus Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - Evolus Earnings release: Q2 2026 - Filings
- 4 days ago - Evolus Slides: Q2 2026 - Filings
- 4 days ago - Evolus Quarterly report: Q2 2026 - Filings
- 4 days ago - Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook - Business Wire
- 5 days ago - Evolus expands strategic partnership with Symatese to commercialize Estyme - TheFly